India warns drugmakers against direct or surrogate weight-loss drug and obesity ads

India warns drugmakers against direct or surrogate weight-loss drug and obesity ads | ReutersSkip to main contentExclusive news, data and analytics for financial market professionalsLearn more aboutRefinitivItem 1 of 2 Vehicles move past a hoarding of Eli Lilly in Gurugram, India, December 16, 2025. REUTERS/Bhawika Chhabra[1/2]Vehicles move past a hoarding of Eli Lilly in Gurugram, India, December 16, 2025. REUTERS/Bhawika Chhabra Purchase Licensing Rights, opens new tab- CompaniesEli Lilly and CoFollowNovo ...